| ٹائم فریم | پیش گوئی کی قیمت | ماضی | تاریخی | بصیرت |
|---|---|---|---|---|
| کل | $3.78 ▼ -0.88% | کل | $3.82 ▲ +0.37% | Tomorrow's SAB Biotherapeutics Inc. Common Stock (SABS) setup is anchored to $3.81 and targets $3.78 (-0.88%). The near-term read is downside; watch $3.92 / $3.70 because daily realized volatility is about 4.56%. |
Tomorrow's SAB Biotherapeutics Inc. Common Stock (SABS) setup is anchored to $3.81 and targets $3.78 (-0.88%). The near-term read is downside; watch $3.92 / $3.70 because daily realized volatility is about 4.56%. | ||||
| ہفتے | $3.71 ▼ -2.75% | آخری ہفتے | $3.85 ▲ +1.16% | The 7-day SAB Biotherapeutics Inc. Common Stock model moves from $3.85 to $3.71 (-2.75%). It gives downside momentum context for this stock, so breaks around $3.92 / $3.70 matter more than a single tick. |
The 7-day SAB Biotherapeutics Inc. Common Stock model moves from $3.85 to $3.71 (-2.75%). It gives downside momentum context for this stock, so breaks around $3.92 / $3.70 matter more than a single tick. | ||||
| مہینہ | $3.59 ▼ -5.86% | پچھلے مہینے | $3.90 ▲ +2.46% | The 1-month SAB Biotherapeutics Inc. Common Stock target is $3.59 (-5.86%), compared with the live reference near $3.81. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month SAB Biotherapeutics Inc. Common Stock target is $3.59 (-5.86%), compared with the live reference near $3.81. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| سال | $3.41 ▼ -10.51% | پچھلے سال | $3.98 ▲ +4.42% | The 1-year SAB Biotherapeutics Inc. Common Stock scenario points to $3.41 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year SAB Biotherapeutics Inc. Common Stock scenario points to $3.41 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 سال | $2.99 ▼ -21.43% | 5 سال پہلے | $4.15 ▲ +9.00% | The 5-year SAB Biotherapeutics Inc. Common Stock view is $2.99 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year SAB Biotherapeutics Inc. Common Stock view is $2.99 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| اشارے | قیمت | اشارہ |
|---|---|---|
| Price | $3.81 | Mid |
| Daily Change | -1.29% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 60% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $3.81 | Daily Change | -1.29% |
| Market Cap | $194.12M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.